Where I see patients (2)
My reviews
5.0
Selected research
-
CUB domain containing protein 1 (CDCP1) is a target for radioligand therapy in castration resistant prostate cancer including PSMA null disease.
Clinical cancer research : an official journal of the American Association for Cancer Research
-
APOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer.
Frontiers in oncology
-
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells.
European urology oncology
Clinical trials
Contact me
- Request appointment
- Refer a patient
- (415) 476-4616